Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 3
1947 1
1948 1
1949 3
1950 1
1951 3
1952 2
1953 3
1954 2
1955 4
1956 4
1957 4
1958 7
1959 2
1960 6
1961 4
1962 2
1963 2
1964 1
1965 2
1966 1
1968 2
1969 2
1970 5
1971 2
1972 4
1974 4
1975 4
1976 2
1977 10
1978 9
1979 7
1980 6
1981 5
1982 7
1983 5
1984 7
1985 10
1986 19
1987 16
1988 21
1989 16
1990 22
1991 12
1992 28
1993 17
1994 22
1995 25
1996 19
1997 27
1998 25
1999 24
2000 23
2001 28
2002 49
2003 29
2004 41
2005 39
2006 45
2007 55
2008 65
2009 70
2010 74
2011 71
2012 85
2013 107
2014 111
2015 142
2016 130
2017 140
2018 157
2019 133
2020 169
2021 158
2022 157
2023 155
2024 62

Text availability

Article attribute

Article type

Publication date

Search Results

2,480 results

Results by year

Filters applied: . Clear all
Page 1
The latest on the role of LAMAs in asthma.
Cazzola M, Rogliani P, Matera MG. Cazzola M, et al. J Allergy Clin Immunol. 2020 Dec;146(6):1288-1291. doi: 10.1016/j.jaci.2020.06.014. Epub 2020 Jun 27. J Allergy Clin Immunol. 2020. PMID: 32603663 No abstract available.
Pharmacology and Therapeutics of Bronchodilators Revisited.
Matera MG, Page CP, Calzetta L, Rogliani P, Cazzola M. Matera MG, et al. Pharmacol Rev. 2020 Jan;72(1):218-252. doi: 10.1124/pr.119.018150. Pharmacol Rev. 2020. PMID: 31848208 Review.
This is currently achieved by use of fixed-dose combinations of inhaled long-acting beta (2)-adrenoceptor agonists (LABAs) and long-acting muscarinic acetylcholine receptor antagonists (LAMAs). Due to the distinct mechanisms of action of LAMAs and LABAs, the additiv …
This is currently achieved by use of fixed-dose combinations of inhaled long-acting beta (2)-adrenoceptor agonists (LABAs) and long-acting m …
The reality of LAMAs for adult asthmatic patients.
Luz MI, Aguiar R, Morais-Almeida M. Luz MI, et al. Expert Rev Respir Med. 2020 Nov;14(11):1087-1094. doi: 10.1080/17476348.2020.1794828. Epub 2020 Jul 20. Expert Rev Respir Med. 2020. PMID: 32687426
There are several studies completed or currently ongoing with the long-acting muscarinic antagonists (LAMAs) umeclidinium and glycopyrronium as an add-on asthma treatment. ...Currently, only tiotropium has been approved and included in the guidelines. Other LAMAs ar …
There are several studies completed or currently ongoing with the long-acting muscarinic antagonists (LAMAs) umeclidinium and glycopy …
HLA genes in Lamas Peruvian-Amazonian Amerindians.
Moscoso J, Seclen S, Serrano-Vela JI, Villena A, Martinez-Laso J, Zamora J, Moreno A, Ira-Cachafeiro J, Arnaiz-Villena A. Moscoso J, et al. Mol Immunol. 2006 Apr;43(11):1881-9. doi: 10.1016/j.molimm.2005.10.013. Epub 2005 Dec 5. Mol Immunol. 2006. PMID: 16337001
The Lamas Amerindians are the Chancas descents who established before 1532 a.d. (Spanish conquest) at Lamas City, Wayku quarter in a Peruvian-Amazonian province (San Martin). ...
The Lamas Amerindians are the Chancas descents who established before 1532 a.d. (Spanish conquest) at Lamas City, Wayku quarte …
FAMILY ASILIDAE.
Wolff M, Lamas CJ. Wolff M, et al. Zootaxa. 2016 Jun 14;4122(1):353-71. doi: 10.11646/zootaxa.4122.1.30. Zootaxa. 2016. PMID: 27395278
Long-acting muscarinic antagonists.
Melani AS. Melani AS. Expert Rev Clin Pharmacol. 2015;8(4):479-501. doi: 10.1586/17512433.2015.1058154. Expert Rev Clin Pharmacol. 2015. PMID: 26109098 Review.
Inhaled bronchodilators are the mainstay of COPD pharmacological treatment. Long-acting muscarinic antagonists (LAMAs) are a major class of inhaled bronchodilators. Some LAMA/device systems with different characteristics and dosing schedules are currently approved for main …
Inhaled bronchodilators are the mainstay of COPD pharmacological treatment. Long-acting muscarinic antagonists (LAMAs) are a major cl …
Muscarinic Receptor Antagonists.
Matera MG, Cazzola M. Matera MG, et al. Handb Exp Pharmacol. 2017;237:41-62. doi: 10.1007/164_2016_68. Handb Exp Pharmacol. 2017. PMID: 27787709 Review.
There are currently six muscarinic receptor antagonists licenced for use in the treatment of COPD, the short-acting muscarinic receptor antagonists (SAMAs) ipratropium bromide and oxitropium bromide and the long-acting muscarinic receptor antagonists (LAMAs) aclidinium bro …
There are currently six muscarinic receptor antagonists licenced for use in the treatment of COPD, the short-acting muscarinic receptor anta …
2,480 results